Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cadmium (Cd), a heavy metal pollutant, contributes to neurodegenerative disorders. Recently, we have demonstrated that Cd induction of reactive oxygen species (ROS) causes apoptosis in neuronal cells. Whether
X-linked inhibitor of apoptosis protein
(
XIAP
) is involved in Cd-induced ROS-dependent neuronal apoptosis remains unclear. Here, we show that Cd-induced ROS reduced the expression of
XIAP
, which resulted in up-regulation of murine double minute 2 homolog (MDM2) and down-regulation of
p53
, leading to apoptosis in PC12 cells and primary neurons. Inhibition of MDM2 with Nutlin-3a reversed Cd-induced reduction of
p53
and substantially rescued cells from excess ROS-dependent death. Overexpression of
XIAP
protected against Cd induction of ROS-dependent neuronal apoptosis. Inhibition of
XIAP
by Embelin strengthened Cd-induced ROS and apoptosis in the cells. Furthermore, we found that Cd inactivation of
XIAP
pathway was attributed to Cd induction of mitochondrial ROS, as evidenced by using a mitochondrial superoxide indicator MitoSOX and a mitochondria-targeted antioxidant Mito-TEMPO. Taken together, these results indicate that Cd induces mitochondrial ROS inactivation of
XIAP
-MDM2-
p53
pathway leading to apoptosis in neuronal cells. Our findings suggest that activators of
XIAP
or modulation of
XIAP
-MDM2-
p53
pathway by antioxidants may be exploited for the prevention of Cd-induced oxidative stress and neurodegenerative diseases.
...
PMID:Cadmium induces mitochondrial ROS inactivation of XIAP pathway leading to apoptosis in neuronal cells. 3203 80
Calycosin is reportedly evidenced with pharmacologically treating bone cells. However, the comprehensive anti-osteosarcoma (OS) mechanisms of calycosin have not been uncovered. By using a systemic method of network pharmacology, the present study aimed to reveal potential anti-OS biotargets and molecular mechanisms played by calycosin. Moreover, human and animal experiments were conducted to verify the core biotargets of calycosin against OS. As results, all primary and core biotargets, biological processes, molecular pathways of calycosin against OS were revealed. Additionally, top 20 biological processes and pathways of calycosin against OS were identified. In human study, the OS sections resulted in reduced expressions of
tumor protein p53
(
TP53
), Caspase-3 (CASP3), and elevated
X-linked inhibitor of apoptosis protein
(
XIAP
) expression in comparison with OS-free controls. As shown in cell culture study, calycosin-treated OS cells showed reduced cell proliferation, and promoted cell apoptosis. In TUNEL stains, calycosin resulted in elevated apoptotic cells. As showed in immunostaining, calycosin-treated OS cells exhibited intracellular up-regulation of
TP53
, CASP3 expressions, and decreased
XIAP
expressions. Taken together, the biological informational findings manifest the candidate and core biotargets, molecular functions and pathways of calycosin against OS. Attractively, these core biotargets may be used for effectively detecting and treating human OS.
...
PMID:Integrative findings indicate anti-tumor biotargets and molecular mechanisms of calycosin against osteosarcoma. 3217 99
<< Previous
1
2
3
4
5
6